Literature DB >> 8003440

The interaction of cytokines in regulating oestradiol 17 beta-hydroxysteroid dehydrogenase activity in MCF-7 cells.

L J Duncan1, N G Coldham, M J Reed.   

Abstract

Oestradiol 17 beta-hydroxysteroid dehydrogenase (E2DH) has a pivotal role in the regulation of oestradiol (E2) concentrations in normal and malignant breast tissues. Previous studies have suggested that a number of cytokines can stimulate E2DH activity to increase the conversion of oestrone (E1) to E2. In this investigation we have examined the effect of TNF alpha, interleukin-1 beta (IL-1 beta) and IL-6 on E2DH activity in MCF-7 breast cancer cells. These cytokines may be produced by breast tumours and their presence in conditioned medium (CM) from tumour-derived fibroblasts was also measured to assess their possible contribution to its E2DH stimulatory activity. Treatment of MCF-7 cells with IL-1 beta and TNF alpha (5 ng/ml) significantly increased (P < 0.001) reductive E2DH (red-E2DH, the conversion of E1 to E2) activity. In contrast, IL-6 at a concentration of 100 ng/ml produced little, if any, stimulation of reductive activity. Combinations of all three cytokines acted synergistically to stimulate red-E2DH activity. No cytokine, either alone or in combination, affected oxidative (E2-->E1) activity. Significant concentrations of IL-6 and IL-1 beta were detected in CM, but the stimulation of red-E2DH activity was much greater than that which could be explained by their levels alone. It is concluded that these cytokines may play an important role in regulating E2DH activity in breast cancer cells and may act synergistically in vivo to enhance the formation of E2 in breast tumours.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8003440     DOI: 10.1016/0960-0760(94)90301-8

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  12 in total

Review 1.  Estrogen metabolism as a regulator of estrogen action in the mammary gland.

Authors:  M Miettinen; V Isomaa; H Peltoketo; D Ghosh; P Vihko
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-07       Impact factor: 2.673

2.  Association of TNF-alpha and TNF-beta gene polymorphism with steroid receptor expression in breast cancer patients.

Authors:  Eskandar Kamali-Sarvestani; Behrouz Gharesi-Fard; Jamal Sarvari; Abd-Al-Rasoul Talei
Journal:  Pathol Oncol Res       Date:  2005-07-01       Impact factor: 3.201

3.  Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF-LTA) and breast cancer risk.

Authors:  Mia M Gaudet; Kathleen M Egan; Jolanta Lissowska; Polly A Newcomb; Louise A Brinton; Linda Titus-Ernstoff; Meredith Yeager; Stephen Chanock; Robert Welch; Beata Peplonska; Amy Trentham-Dietz; Montserrat Garcia-Closas
Journal:  Hum Genet       Date:  2007-01-11       Impact factor: 4.132

4.  Genetic variation in proinflammatory cytokines IL6, IL6R, TNF-region, and TNFRSF1A and risk of breast cancer.

Authors:  Margaret M Madeleine; Lisa G Johnson; Mari Malkki; Alexa J Resler; Effie W Petersdorf; Barbara McKnight; Kathleen E Malone
Journal:  Breast Cancer Res Treat       Date:  2011-04-27       Impact factor: 4.872

5.  Synergistic up-regulation of prostaglandin E synthase expression in breast cancer cells by 17beta-estradiol and proinflammatory cytokines.

Authors:  Jonna Frasor; Aisha E Weaver; Madhumita Pradhan; Kinnari Mehta
Journal:  Endocrinology       Date:  2008-08-14       Impact factor: 4.736

6.  Tumor necrosis factor alpha and interleukin 1beta enhance the cortisone/cortisol shuttle.

Authors:  G Escher; I Galli; B S Vishwanath; B M Frey; F J Frey
Journal:  J Exp Med       Date:  1997-07-21       Impact factor: 14.307

Review 7.  The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer.

Authors:  Atul Purohit; Simon P Newman; Michael J Reed
Journal:  Breast Cancer Res       Date:  2002-01-14       Impact factor: 6.466

8.  Modulation of oestrone sulphate formation and hydrolysis in breast cancer cells by breast cyst fluid from British and Hungarian women.

Authors:  A Purohit; B Budai; D Y Wang; E L Willemsen; A de Winkel; D Parish; M W Ghilchik; I Szamel; M J Reed
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

9.  Direct activation of oestrogen receptor-alpha by interleukin-6 in primary cultures of breast cancer epithelial cells.

Authors:  V Speirs; M J Kerin; D S Walton; C J Newton; S B Desai; S L Atkin
Journal:  Br J Cancer       Date:  2000-04       Impact factor: 7.640

10.  Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients.

Authors:  T Bachelot; I Ray-Coquard; C Menetrier-Caux; M Rastkha; A Duc; J-Y Blay
Journal:  Br J Cancer       Date:  2003-06-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.